Forecast
Period
|
2026-2030
|
Market
Size (2024)
|
USD
210.75 Million
|
Market
Size (2030)
|
USD
346.52 Million
|
CAGR
(2025-2030)
|
8.60%
|
Fastest
Growing Segment
|
Reagents
& Kits
|
Largest
Market
|
West
Region
|
Market Overview
United
States Nutrigenomics Market was valued at USD 210.75 Million in 2024 and is
anticipated to project impressive growth in the forecast period with a CAGR of 8.60%
through 2030. The
United States Nutrigenomics Market is a rapidly expanding segment within the
personalized nutrition and healthcare industry, driven by growing consumer
demand for tailored dietary solutions and advancements in genetic research.
Nutrigenomics, which explores the interaction between nutrition and an
individual’s genetic profile, is gaining momentum as both consumers and
healthcare providers recognize its potential to enhance health outcomes and
prevent diseases.
With
rising awareness of personalized nutrition, individuals are increasingly
seeking customized dietary recommendations based on their genetic composition,
lifestyle factors, and existing health conditions. This scientific approach
enables the development of precision-based nutrition plans, optimizing health
and mitigating the risk of chronic diseases.
The
market is poised for substantial growth, fueled by technological innovations,
greater accessibility to genetic testing, and increasing consumer interest in
preventive healthcare. However, challenges such as high costs, regulatory
complexities, and data privacy concerns remain key considerations. Despite
these hurdles, nutrigenomics is positioned to redefine the future of nutrition
and preventive medicine, establishing itself as a core component of precision
healthcare. As the industry evolves, its ability to deliver personalized,
science-backed nutritional strategies will play a pivotal role in improving
long-term health and wellness outcomes.
Key Market Drivers
Increasing Prevalence of
Chronic
The
rising prevalence of chronic diseases in the United States is a major driver
fueling the growth of the nutrigenomics market. As lifestyle-related health
conditions such as obesity, diabetes, cardiovascular diseases, metabolic
disorders, and gastrointestinal issues continue to escalate, consumers,
healthcare providers, and businesses are turning to nutrigenomics as a
preventive and personalized approach to health management. Chronic diseases
account for a significant portion of healthcare costs and mortality in the U.S.
According to the Centers for Disease Control and Prevention (CDC):6 in 10
adults in the U.S. have at least one chronic disease. 4 in 10 adults suffer
from two or more chronic conditions. Chronic diseases account for nearly
90% of the nation’s USD4.1 trillion in annual healthcare costs. This growing
burden has created a demand for proactive health solutions, leading to the
increased adoption of nutrigenomics-based personalized nutrition to mitigate
disease risks and improve patient outcomes.
Traditionally,
chronic diseases have been managed through pharmaceutical interventions and
lifestyle modifications. However, there is a growing paradigm shift towards
preventive healthcare, where individuals seek solutions to prevent disease
onset rather than merely treating symptoms. Genetic risk assessments for
diseases like Type 2 diabetes, hypertension, and obesity. In 2021, an
estimated 38.4 million individuals across all age groups in the United States—11.6%
of the total population—were diagnosed with diabetes. Among adults aged 18
years and older, 38.1 million individuals, accounting for 14.7% of the adult
population, had diabetes. Additionally, 8.7 million adults met laboratory
criteria for diabetes but were either unaware of their condition or had not
reported a diagnosis. This undiagnosed population represents 3.4% of all U.S.
adults and a substantial 22.8% of the total diabetic adult population,
highlighting a critical gap in diagnosis and healthcare awareness.
Personalized
dietary plans tailored to an individual’s genetic makeup to optimize metabolism
and reduce disease susceptibility. Early intervention strategies that allow
individuals to make informed nutritional choices before diseases manifest. This
shift from reactive to proactive healthcare is accelerating the adoption of
nutrigenomics among both consumers and healthcare providers. Consumers are
increasingly recognizing the role that genetics play in metabolism, nutrient
absorption, and overall health. Many chronic diseases, such as Type 2 diabetes
and cardiovascular diseases, have a genetic component that influences how the
body processes certain nutrients. Identify genetic predispositions to
conditions like insulin resistance, high cholesterol, and inflammatory
disorders. Make evidence-based dietary adjustments to manage and reduce disease
risks. Move towards DNA-based nutrition planning that goes beyond generic diet
trends, improving long-term health outcomes. This awareness is fueling consumer
demand for nutrigenomics-based services, supplements, and dietary plans,
driving market growth.
The
medical and wellness industries are integrating nutrigenomics-based solutions
into chronic disease management programs. Hospitals, clinics, and nutritionists
are utilizing genetic insights to design customized dietary interventions for
patients with obesity, diabetes, and cardiovascular diseases. Heart disease remains the leading cause of mortality across all demographics, including men, women, and individuals from diverse racial and ethnic backgrounds. On average, one person succumbs to cardiovascular disease every 33 seconds. In 2022 alone, heart disease claimed 702,880 lives, accounting for one in every five deaths nationwide. Pharmaceutical
and nutraceutical companies are leveraging nutrigenomics to develop targeted
supplements and functional foods tailored to individuals with genetic
predispositions to chronic illnesses. Insurance companies and corporate
wellness programs are exploring nutrigenomics-based health plans to reduce
long-term healthcare costs by emphasizing prevention. As healthcare providers
increasingly incorporate genetic-based nutrition into patient care, the demand
for nutrigenomics services and testing kits continues to surge. The rise of
direct-to-consumer (DTC) genetic testing kits has made nutrigenomics more
accessible to individuals looking to manage or prevent chronic conditions.
Companies such as 23andMe, DNAfit, and Nutrigenomix are offering DNA-based
health insights that include genetic predisposition to obesity, heart disease,
and diabetes, along with tailored dietary recommendations. Additionally,
AI-driven health apps and wearable technology are integrating nutrigenomic data
to provide real-time, customized nutritional guidance. This accessibility is
empowering individuals to take control of their health, further boosting the
nutrigenomics market.
Rising Demand for Personalized
Nutrition
The
United States Nutrigenomics Market is witnessing substantial growth, with
rising demand for personalized nutrition emerging as one of its primary
drivers. The demand for personalized nutrition products is rapidly growing among North American consumers. In the United States, 46% of consumers express a strong interest in receiving customized health advice and solutions tailored to their individual needs. Similarly, in Canada, 55% of adults indicate interest in DNA-based nutritional plans, highlighting a significant market opportunity for genetic-driven wellness solutions. Consumers are moving away from generic dietary recommendations and
embracing tailored nutrition plans that cater to their unique genetic makeup,
metabolism, and health conditions. This shift is fueling innovation and
investment in nutrigenomics, making it a key sector in the future of precision
health and wellness. The traditional approach to nutrition follows general
dietary guidelines that apply broadly to the population. However, research has
demonstrated that individuals metabolize and respond to foods differently based
on their genetic profile. This has led to a shift toward precision nutrition,
where dietary recommendations are based on a person’s unique genetic
predispositions. DNA-based dietary recommendations tailored to metabolism,
nutrient absorption, and food intolerances. Optimized diet plans to prevent
disease, enhance wellness, and improve long-term health outcomes. Scientific
personalization of nutrition for specific health goals, such as weight
management, heart health, and digestive health. This transition from
generalized to personalized nutrition is a fundamental driver behind the
increasing adoption of nutrigenomics-based solutions in the U.S.
Modern
consumers are more informed than ever about the role of nutrition in overall
health and longevity. With increasing awareness of nutrient-gene interactions,
individuals are actively seeking solutions that help them: Identify how their
genes impact their metabolism and food sensitivities (e.g., lactose or gluten
intolerance). Choose diets that enhance energy levels, improve digestion, and
optimize weight management. Reduce the risk of chronic diseases such as
diabetes, cardiovascular conditions, and obesity through targeted dietary
interventions. The demand for science-backed, personalized diet plans is
leading to greater consumer interest in nutrigenomics-based products and
services, driving market expansion. The rise of affordable genetic testing
technologies, including Next-Generation Sequencing (NGS) and Polymerase Chain
Reaction (PCR), has made DNA-based nutritional analysis more accessible. Lowered
the cost of genetic testing, making it available to a broader consumer base. Improved
the accuracy of genetic-based nutritional recommendations. Enabled the
integration of artificial intelligence (AI) and big data to analyze genetic
profiles and provide real-time, customized dietary guidance. With technology
making personalized nutrition easier and more cost-effective, more consumers
and businesses are entering the nutrigenomics space, fueling further market
growth.
The
emergence of direct-to-consumer (DTC) genetic testing kits has played a
significant role in the growing demand for personalized nutrition. Companies
such as 23andMe, DNAfit, and Nutrigenomix offer easy-to-use home testing kits,
enabling consumers to gain insights into their genetic predisposition for: Metabolism
and weight management, Nutrient absorption efficiency (e.g., vitamins and
minerals), Food intolerances and sensitivities. These insights empower
individuals to customize their diet and supplement intake accordingly. The
increasing adoption of DTC genetic tests has significantly expanded the
consumer base for nutrigenomics, boosting the market’s growth potential. With
personalized nutrition becoming mainstream, the demand for customized
functional foods and nutraceuticals is surging. DNA-based supplement
formulations tailored to genetic deficiencies. Personalized meal plans and food
products designed for specific genetic traits. Custom protein blends and
performance-enhancing diets for fitness and athletic goals. The integration of
nutrigenomics with the functional food industry is creating lucrative business
opportunities for food and beverage companies, nutraceutical firms, and
healthcare providers.
Advancements in Genomic
Research and Technology
The
United States Nutrigenomics Market is experiencing significant growth,
primarily fueled by advancements in genomic research and technology. The
continuous evolution of genetic sequencing, bioinformatics, AI-driven data
analysis, and molecular diagnostics has improved the accessibility, accuracy,
and affordability of genetic-based nutritional insights. These technological
advancements are revolutionizing the way individuals and healthcare providers
approach personalized nutrition, driving demand and market expansion. One of
the most significant technological advancements driving the growth of the
nutrigenomics market is the dramatic reduction in the cost of genetic
sequencing. This affordability has made genetic testing more accessible to
consumers, healthcare providers, and research institutions. Next-Generation
Sequencing (NGS) and Polymerase Chain Reaction (PCR) technologies have enhanced
the precision of genetic analysis, allowing for more accurate and comprehensive
nutrigenomic profiling. As genetic testing becomes affordable and scalable,
more consumers and businesses are adopting nutrigenomics-based solutions,
fueling market growth.
Enhancing
the accuracy of genetic-based dietary recommendations. Processing massive
datasets to identify patterns in gene-nutrient interactions. Developing
predictive models that allow individuals to optimize their diet and lifestyle
based on their genetic profile. Companies are leveraging AI-driven personalized
nutrition platforms to provide real-time, science-backed dietary suggestions.
The automation and scalability of AI-based nutrigenomic solutions are
attracting investments from biotech firms, healthcare providers, and consumer
health brands, contributing to rapid industry growth. Technological
advancements have enabled the rise of direct-to-consumer (DTC) genetic testing
kits, making nutrigenomics more accessible to the general public. Nutrient
absorption rates (e.g., vitamins, minerals, and macronutrients). Food
intolerances and sensitivities based on genetic markers. The proliferation of
user-friendly, AI-powered genetic testing kits has significantly increased
consumer interest in DNA-based nutrition, leading to higher adoption rates and
market expansion.
Scientific
advancements in molecular biology and functional genomics are unlocking new
possibilities in nutrigenomics. Researchers are identifying specific gene-diet
interactions that influence health conditions like diabetes, cardiovascular
disease, and obesity. Advancements in epigenetics (the study of how genes are
influenced by lifestyle and environmental factors) are helping tailor
personalized nutrition plans. Microbiome research (the study of gut bacteria
and its impact on health) is becoming an essential component of DNA-based
dietary recommendations. These breakthroughs are driving innovation in
precision nutrition, making nutrigenomics a core pillar of personalized
healthcare and wellness solutions. Pharmaceutical companies are investing in
nutrigenomics to develop personalized supplements and therapeutic diets. Hospitals
and clinics are integrating DNA-based nutrition into preventive healthcare
programs. Insurance providers are exploring nutrigenomics-based wellness plans
to reduce long-term healthcare costs. These cross-industry collaborations are
expanding the commercial applications of nutrigenomics, boosting demand and
accelerating market growth.

Download Free Sample Report
Key Market Challenges
High Costs and Limited
Accessibility
Despite
advancements in genetic sequencing and personalized nutrition, the high cost of
nutrigenomics-based testing and services remains a significant barrier to
widespread adoption.
Although
the cost of genome sequencing has decreased significantly, comprehensive
nutrigenomics tests can still range from USD200 to over USD1,000, making them
unaffordable for many consumers. Most health insurance plans in the U.S. do not
cover nutrigenomics testing or personalized dietary consultations, making it a
self-pay expense that restricts market penetration. Companies investing in
nutrigenomics-based products and services face high research and development
(R&D) costs due to the complex nature of gene-nutrient interactions and the
need for advanced bioinformatics platforms. Access to genetic testing
facilities and expert nutrigenomics practitioners is often concentrated in
urban areas, leaving rural populations with fewer opportunities to benefit from
these services.
The
high cost structure limits consumer adoption, particularly among middle- and
lower-income demographics. Businesses face challenges in scaling nutrigenomics
services, as affordability concerns hinder mass-market expansion. Without
insurance reimbursement models, nutrigenomics remains a luxury product rather
than a mainstream healthcare solution.
Regulatory and Ethical
Concerns
The
nutrigenomics industry operates in a complex regulatory environment, with data
privacy, ethical concerns, and lack of standardized guidelines posing
significant challenges.
The
FDA, FTC, and other regulatory agencies have yet to establish comprehensive,
standardized regulations for nutrigenomics testing and dietary recommendations.
Nutrigenomics involves the collection and analysis of sensitive genetic data,
raising concerns about data breaches, misuse of personal health information,
and third-party data sharing. Some critics argue that genetic-based dietary
recommendations could lead to genetic discrimination in areas such as
employment and insurance coverage. There is also concern over misleading claims
made by nutrigenomics companies regarding the effectiveness of genetic-based
diets. Many direct-to-consumer (DTC) nutrigenomics companies operate without
strict oversight, leading to variability in test accuracy and the reliability
of dietary recommendations.
Regulatory
uncertainty discourages large-scale investments from healthcare and biotech
companies. Consumer skepticism due to privacy concerns and lack of industry
regulation hinders adoption. Companies face legal risks related to compliance
with HIPAA, GDPR, and evolving genetic privacy laws.
Key Market Trends
The Rise of Consumer-Led
Health and Wellness Movements
A
significant trend shaping the future of the nutrigenomics market is the shift
toward consumer-driven health and wellness solutions. Unlike traditional
healthcare, where interventions are often reactive, today’s consumers are
increasingly adopting a proactive approach to nutrition and disease prevention.
Consumers are moving away from one-size-fits-all diets and opting for
personalized nutritional plans based on genetic insights. There is a rising
interest in genetically informed dietary supplements and functional foods that
align with an individual’s DNA profile. Wearable devices, mobile health apps,
and home-testing kits are empowering consumers to track biomarkers, analyze
nutrient levels, and make informed dietary decisions.
Retail
and e-commerce platforms are integrating nutrigenomics-based products, creating
new revenue channels for businesses. Wellness-focused brands are leveraging
genetic data to develop customized meal plans, supplements, and health
subscriptions. The shift toward self-directed healthcare is accelerating
partnerships between nutrigenomics companies, fitness brands, and telehealth
providers.
Expansion of Corporate
Wellness and Employer-Sponsored Nutrition Programs
As
organizations recognize the long-term financial benefits of preventive
healthcare, many are incorporating nutrigenomics-based wellness programs into
their employee benefits packages. This corporate-driven adoption is fueling the
next phase of nutrigenomics market expansion.
Companies
are investing in preventive health strategies, including genetic-based
nutrition plans, to reduce healthcare expenses associated with chronic diseases
such as diabetes, obesity, and cardiovascular disorders. Leading employers are
introducing DNA-driven nutrition plans as part of workplace wellness
initiatives, offering employees access to genetic testing, diet
recommendations, and targeted supplementation. Some insurance providers are
beginning to explore coverage for nutrigenomics-based health assessments,
aligning with broader trends in personalized medicine.
B2B
partnerships between nutrigenomics firms and corporate wellness providers are
creating new growth avenues. Companies offering genetic-based nutrition
programs are securing long-term contracts with large employers, healthcare
insurers, and benefits providers. Employers implementing nutrigenomics-backed
dietary interventions see improved employee productivity, reduced absenteeism,
and lower healthcare costs.
Segmental Insights
Product Insights
Based
on the category of Product, the Reagents & Kits segment emerged as the
dominant segment in the United States Nutrigenomics market in 2024. This is due
to its essential role in genetic testing, biomarker analysis, and personalized
nutrition research. As the backbone of nutrigenomics applications, reagents and
kits are widely used in laboratories, research institutions, and
direct-to-consumer (DTC) genetic testing services. Their dominance is driven by
increasing demand for genetic-based dietary insights, continuous advancements
in molecular diagnostics, and the rise of home-based DNA testing kits. The
growth of the nutrigenomics industry is closely linked to the rising adoption
of genetic testing services for personalized dietary recommendations. Reagents
and kits form the core components of these testing processes, making them
indispensable in the market.
Nutrigenomics
relies on genetic markers such as SNPs (Single Nucleotide Polymorphisms) to
assess an individual’s response to different nutrients. Reagents such as DNA
polymerases, nucleotides, and primers play a crucial role in amplifying and
analyzing these markers. The popularity of direct-to-consumer (DTC) genetic
testing has surged, with major players such as 23andMe and DNAfit offering
nutrition-based DNA analysis kits. These testing kits require specialized
reagents for sample collection, DNA extraction, and sequencing. Healthcare
providers and research institutions are increasingly using nutrigenomics
testing kits for personalized disease prevention, obesity management, and
metabolic health optimization. These factors are expected to drive the growth
of this segment.
Application Insights
The
Obesity segment is projected to experience rapid growth during the forecast
period. This is due to the rising prevalence of obesity-related health
conditions, the increasing demand for personalized weight management solutions,
and the growing integration of genetic-based interventions into preventive
healthcare. With obesity rates in the U.S. reaching alarming levels,
nutrigenomics has emerged as a highly effective approach to understanding the
genetic basis of weight gain, metabolism, and dietary response. This has led to
the widespread adoption of genetic testing, personalized meal planning, and DNA-based
weight management programs, solidifying obesity as the dominant application
area in the nutrigenomics market. Obesity is a major public health crisis in
the United States, with over 40% of adults classified as obese according to the
CDC. Traditional weight loss programs often fail to deliver long-term
sustainable results due to genetic variations in metabolism, fat storage, and
appetite regulation. Nutrigenomics provides a personalized, science-backed
approach to weight management by analyzing an individual's genetic
predisposition to obesity and tailoring dietary recommendations accordingly.
Variations
in genes such as FTO (fat mass and obesity-associated gene) and MC4R
(melanocortin-4 receptor) influence how individuals store and burn fat. Nutrigenomics
testing helps determine optimal macronutrient ratios, meal timing, and dietary
restrictions based on an individual's genetic profile. Unlike generic diet
plans, DNA-based nutritional interventions offer a customized approach tailored
to genetic markers that affect insulin resistance, satiety levels, and lipid
metabolism. Consumers are increasingly seeking scientific, evidence-based
weight loss solutions rather than trial-and-error dieting methods. Nutrigenomics
testing provides clear, actionable dietary guidelines based on an individual's
genetic makeup, leading to higher adoption. These factors contribute to the
growth of this segment.

Download Free Sample Report
Regional Insights
West
emerged as the dominant region in the United States Nutrigenomics market in 2024,
holding the largest market share in terms of value. The West Region holds a
dominant position in the United States Nutrigenomics Market, driven by its
strong presence of biotechnology hubs, high consumer awareness of personalized
nutrition, and the widespread adoption of genetic testing for health optimization.
This region, which includes California, Washington, Oregon, and other western
states, has become the center of innovation in nutrigenomics research,
direct-to-consumer (DTC) genetic testing services, and AI-driven personalized
nutrition solutions. With a high concentration of tech-driven healthcare
companies, top-tier research institutions, and an affluent consumer base
actively seeking advanced wellness solutions, the West Region has emerged as
the largest contributor to the U.S. nutrigenomics market.
Key Market Players
- BioGaia
- DuPont de Nemours, Inc.
- Nutrigenomix Inc.
- Metagenics, Inc.
- Genova Diagnostics, Inc.
- DNA fit
- MedGenome
- Garden of Life, LLC.
- GeneOmbio
- WellGen Inc
By
Application
|
By
Product
|
By
Technique
|
By
End User
|
By
Region
|
- Obesity
- Cardiovascular
Diseases
- Cancer
Research
- Others
|
|
|
- Hospitals
& Clinics
- Others
|
- North-East
- Mid-West
- West
- South
|
Report Scope:
In this report, the United States Nutrigenomics
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- United States Nutrigenomics Market, By Application:
o Obesity
o Cardiovascular Diseases
o Cancer Research
o Others
- United States Nutrigenomics Market, By Product:
o Reagents & Kits
o Services
- United States Nutrigenomics Market, By Technique:
o Saliva
o Buccal Swab
o Blood
- United States Nutrigenomics Market, By End User:
o Hospitals & Clinics
o Others
- United States Nutrigenomics Market, By Region:
o North-East
o Mid-West
o West
o South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United
States Nutrigenomics Market.
Available Customizations:
United
States Nutrigenomics market report with the given market data, TechSci
Research offers customizations according to a company's specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
United States Nutrigenomics Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]